שווי מתואם לחוב ומזומנים: TuHURA Biosciences, Inc. (HURA)

The price chart for TuHURA Biosciences, Inc. (HURA) reflects a business valuation that currently stands at 134.57. The company's revenue will be based on the commercialization of personalized vaccines and immune stimulants. The current state is characterized by the depletion of reserves due to testing costs amid zero sales. Meanwhile, skilled management is focusing on developing cutting-edge therapeutic systems while raising funds to complete trials.

Defensive assets are selected based on the criterion of undervalued acquisition costs, which is critical for TuHURA Biosciences (HURA) and its developments in the field of anti-cancer vaccines. The current value of 134.57 reflects the real business price, summing market capitalization and debt minus cash, allowing the use of a historical enterprise value chart to identify entry points without the risk of overpaying for the asset.